American International Group, Inc. Madrigal Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$171.37 - $283.23 $10,624 - $17,560	-62 Reduced 0.84%	7,292 $1.95 Million
Q4 2023 Feb 13, 2024	BUY	$120.4 - $237.13 $67,183 - $132,318	558 Added 8.21%	7,354 $1.7 Million
Q3 2023 Nov 13, 2023	BUY	$146.04 - $225.78 $35,195 - $54,412	241 Added 3.68%	6,796 $992,000
Q2 2023 Aug 04, 2023	BUY	$203.88 - $312.0 $83,590 - $127,920	410 Added 6.67%	6,555 $1.51 Million
Q1 2023 May 12, 2023	BUY	$231.06 - $307.08 $28,420 - $37,770	123 Added 2.04%	6,145 $1.49 Million
Q4 2022 Feb 10, 2023	SELL	$58.39 - $296.54 $1,284 - $6,523	-22 Reduced 0.36%	6,022 $1.75 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $5,209 - $6,837	86 Added 1.44%	6,044 $393,000
Q2 2022 Aug 12, 2022	BUY	$58.04 - $100.2 $6,558 - $11,322	113 Added 1.93%	5,958 $426,000
Q1 2022 May 13, 2022	SELL	$55.89 - $101.89 $23,026 - $41,978	-412 Reduced 6.58%	5,845 $574,000
Q4 2021 Feb 11, 2022	BUY	$72.34 - $95.09 $3,110 - $4,088	43 Added 0.69%	6,257 $530,000
Q3 2021 Nov 12, 2021	SELL	$78.35 - $105.02 $11,595 - $15,542	-148 Reduced 2.33%	6,214 $496,000
Q2 2021 Aug 13, 2021	BUY	$97.2 - $137.59 $122,763 - $173,776	1,263 Added 24.77%	6,362 $620,000
Q1 2021 May 07, 2021	BUY	$108.54 - $125.2 $1,519 - $1,752	14 Added 0.28%	5,099 $596,000
Q4 2020 Feb 12, 2021	SELL	$110.06 - $133.7 $16,068 - $19,520	-146 Reduced 2.79%	5,085 $565,000
Q3 2020 Nov 04, 2020	SELL	$99.78 - $124.21 $11,873 - $14,780	-119 Reduced 2.22%	5,231 $621,000
Q2 2020 Aug 12, 2020	BUY	$60.13 - $125.71 $481 - $1,005	8 Added 0.15%	5,350 $606,000
Q1 2020 May 04, 2020	BUY	$66.76 - $93.49 $29,975 - $41,977	449 Added 9.18%	5,342 $357,000
Q4 2019 Feb 05, 2020	SELL	$84.28 - $118.5 $3,455 - $4,858	-41 Reduced 0.83%	4,893 $446,000
Q3 2019 Nov 08, 2019	SELL	$84.4 - $106.53 $2,954 - $3,728	-35 Reduced 0.7%	4,934 $425,000
Q2 2019 Aug 13, 2019	BUY	$91.13 - $142.5 $49,665 - $77,662	545 Added 12.32%	4,969 $521,000
Q1 2019 May 06, 2019	SELL	$103.48 - $143.84 $14,901 - $20,712	-144 Reduced 3.15%	4,424 $554,000
Q4 2018 Feb 13, 2019	SELL	$94.77 - $215.54 $3,316 - $7,543	-35 Reduced 0.76%	4,568 $515,000
Q3 2018 Nov 09, 2018	BUY	$207.3 - $300.31 $169,571 - $245,653	818 Added 21.61%	4,603 $986,000
Q2 2018 Aug 08, 2018	BUY	$101.55 - $313.9 $77,482 - $239,505	763 Added 25.25%	3,785 $1.06 Million
Q1 2018 May 07, 2018	BUY	$93.35 - $149.04 $21,003 - $33,534	225 Added 8.04%	3,022 $353,000
Q4 2017 Feb 09, 2018	BUY	$39.35 - $97.37 $3,423 - $8,471	87 Added 3.21%	2,797 $257,000
Q3 2017 Nov 09, 2017	BUY	$15.48 - $46.19 $41,950 - $125,174	2,710	2,710 $122,000

Others Institutions Holding MDGL

# of Institutions

296

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

Janus Henderson Group PLC London, X0

2.48M
Shares

$861 Million
0.28% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$709 Million
29.57% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$705 Million
6.48% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$693 Million
6.74% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$686 Million
4.49% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account